The dissertation under examination conducts a thorough examination of the intricate dynamics between the public health system and pharmaceutical patents. Its primary focus lies in assessing the adequacy of the balance between upholding the rights of patent owners and guaranteeing sufficient access to public health resources. This inquiry is contextualised within the framework of previous epidemics and the distinctive challenges brought forth by the Covid-19 pandemic. The research aims to impartially analyse the complexities at the intersection of legal and public health domains, with the goal of unravelling the effectiveness and equity of existing systems in facilitating access to crucial pharmaceuticals during times of health crises.